Feifel et al. found that a three-week, twice-daily, 40 IU intranasal oxytocin treatment improved the verbal memory measured by the California Verbal Learning Test but not the working memory measured by the letter number sequence in patients with schizophrenia [153]. This evidence concerns the gene OXT and schizophrenia.